VIM and Miyoshi myopathy: Consistently, gene expression and immunofluorescence analyses indicated that CAF in symptomatic MM patients express significant higher levels of structural proteins as α-SMA and vimentin, recognized as fibroblast activation markers, and the metalloproteinase MMP-2.